Stanisic, Sanja, Antonio Bertolotto, Patrizia Berto, Paolo Di Procolo, and Julia Morawski. “The Cost-Effectiveness of Alemtuzumab in the Management of Relapse-Remitting Multiple Sclerosis in Italy”. Global & Regional Health Technology Assessment 6, no. 1 (April 10, 2019). Accessed August 15, 2022. https://journals.aboutscience.eu/index.php/grhta/article/view/465.